nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP1A2—Carmustine—lymphatic system cancer	0.16	0.234	CbGbCtD
Ticlopidine—CYP2E1—Mitoxantrone—lymphatic system cancer	0.13	0.19	CbGbCtD
Ticlopidine—CYP2C19—Teniposide—lymphatic system cancer	0.116	0.17	CbGbCtD
Ticlopidine—CYP2C9—Teniposide—lymphatic system cancer	0.0966	0.142	CbGbCtD
Ticlopidine—CYP3A4—Cytarabine—lymphatic system cancer	0.057	0.0837	CbGbCtD
Ticlopidine—CYP3A4—Teniposide—lymphatic system cancer	0.0562	0.0824	CbGbCtD
Ticlopidine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0393	0.0576	CbGbCtD
Ticlopidine—CYP3A4—Vincristine—lymphatic system cancer	0.027	0.0397	CbGbCtD
Ticlopidine—Leukaemia—Teniposide—lymphatic system cancer	0.0166	0.052	CcSEcCtD
Ticlopidine—Alveolitis allergic—Fludarabine—lymphatic system cancer	0.015	0.0472	CcSEcCtD
Ticlopidine—Leukaemia—Vincristine—lymphatic system cancer	0.00889	0.0279	CcSEcCtD
Ticlopidine—Bone marrow depression—Teniposide—lymphatic system cancer	0.00661	0.0208	CcSEcCtD
Ticlopidine—Bone marrow depression—Fludarabine—lymphatic system cancer	0.00581	0.0182	CcSEcCtD
Ticlopidine—Haemolytic anaemia—Mechlorethamine—lymphatic system cancer	0.00486	0.0153	CcSEcCtD
Ticlopidine—Alveolitis allergic—Methotrexate—lymphatic system cancer	0.00445	0.014	CcSEcCtD
Ticlopidine—Leukaemia—Methotrexate—lymphatic system cancer	0.00431	0.0136	CcSEcCtD
Ticlopidine—Sepsis—Teniposide—lymphatic system cancer	0.00387	0.0122	CcSEcCtD
Ticlopidine—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.0036	0.0113	CcSEcCtD
Ticlopidine—Haemolytic anaemia—Teniposide—lymphatic system cancer	0.00359	0.0113	CcSEcCtD
Ticlopidine—Bone marrow depression—Vincristine—lymphatic system cancer	0.00355	0.0111	CcSEcCtD
Ticlopidine—Bone marrow depression—Mitoxantrone—lymphatic system cancer	0.00345	0.0109	CcSEcCtD
Ticlopidine—Hepatic failure—Fludarabine—lymphatic system cancer	0.00317	0.00995	CcSEcCtD
Ticlopidine—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00305	0.00959	CcSEcCtD
Ticlopidine—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00304	0.00954	CcSEcCtD
Ticlopidine—Liver function test abnormal—Teniposide—lymphatic system cancer	0.00299	0.00939	CcSEcCtD
Ticlopidine—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00287	0.00902	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Fludarabine—lymphatic system cancer	0.00285	0.00894	CcSEcCtD
Ticlopidine—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00283	0.0089	CcSEcCtD
Ticlopidine—Contusion—Mitoxantrone—lymphatic system cancer	0.00267	0.0084	CcSEcCtD
Ticlopidine—Pancytopenia—Teniposide—lymphatic system cancer	0.00266	0.00835	CcSEcCtD
Ticlopidine—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.00263	0.00825	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.00245	0.00768	CcSEcCtD
Ticlopidine—Nephropathy—Methotrexate—lymphatic system cancer	0.00244	0.00767	CcSEcCtD
Ticlopidine—Pancytopenia—Fludarabine—lymphatic system cancer	0.00234	0.00734	CcSEcCtD
Ticlopidine—Haemoglobin—Teniposide—lymphatic system cancer	0.00225	0.00707	CcSEcCtD
Ticlopidine—Haemorrhage—Teniposide—lymphatic system cancer	0.00224	0.00704	CcSEcCtD
Ticlopidine—Sepsis—Carmustine—lymphatic system cancer	0.00218	0.00684	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00217	0.00683	CcSEcCtD
Ticlopidine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00216	0.00678	CcSEcCtD
Ticlopidine—Renal failure—Fludarabine—lymphatic system cancer	0.00216	0.00677	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00215	0.00675	CcSEcCtD
Ticlopidine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00211	0.00664	CcSEcCtD
Ticlopidine—Ecchymosis—Mitoxantrone—lymphatic system cancer	0.00211	0.00662	CcSEcCtD
Ticlopidine—Diabetes mellitus—Carmustine—lymphatic system cancer	0.00209	0.00658	CcSEcCtD
Ticlopidine—Haematuria—Fludarabine—lymphatic system cancer	0.00209	0.00657	CcSEcCtD
Ticlopidine—Epistaxis—Fludarabine—lymphatic system cancer	0.00207	0.0065	CcSEcCtD
Ticlopidine—Anorexia—Mechlorethamine—lymphatic system cancer	0.00206	0.00646	CcSEcCtD
Ticlopidine—Sepsis—Mitoxantrone—lymphatic system cancer	0.00202	0.00636	CcSEcCtD
Ticlopidine—Haemoglobin—Fludarabine—lymphatic system cancer	0.00198	0.00622	CcSEcCtD
Ticlopidine—Haemorrhage—Fludarabine—lymphatic system cancer	0.00197	0.00618	CcSEcCtD
Ticlopidine—Hepatic failure—Vincristine—lymphatic system cancer	0.00193	0.00608	CcSEcCtD
Ticlopidine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00188	0.00589	CcSEcCtD
Ticlopidine—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00186	0.00585	CcSEcCtD
Ticlopidine—Hyponatraemia—Carmustine—lymphatic system cancer	0.00183	0.00574	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.00182	0.00572	CcSEcCtD
Ticlopidine—Hyponatraemia—Vincristine—lymphatic system cancer	0.00175	0.00548	CcSEcCtD
Ticlopidine—Bone marrow depression—Methotrexate—lymphatic system cancer	0.00172	0.00541	CcSEcCtD
Ticlopidine—Pancytopenia—Bleomycin—lymphatic system cancer	0.00171	0.00538	CcSEcCtD
Ticlopidine—Hyponatraemia—Mitoxantrone—lymphatic system cancer	0.0017	0.00534	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00169	0.00532	CcSEcCtD
Ticlopidine—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00168	0.00528	CcSEcCtD
Ticlopidine—Lung disorder—Methotrexate—lymphatic system cancer	0.00164	0.00516	CcSEcCtD
Ticlopidine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00159	0.005	CcSEcCtD
Ticlopidine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00156	0.00489	CcSEcCtD
Ticlopidine—Haematuria—Bleomycin—lymphatic system cancer	0.00153	0.00482	CcSEcCtD
Ticlopidine—Pruritus—Mechlorethamine—lymphatic system cancer	0.00153	0.0048	CcSEcCtD
Ticlopidine—Anorexia—Teniposide—lymphatic system cancer	0.00152	0.00477	CcSEcCtD
Ticlopidine—Pancytopenia—Carmustine—lymphatic system cancer	0.00149	0.0047	CcSEcCtD
Ticlopidine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00148	0.00464	CcSEcCtD
Ticlopidine—Myalgia—Fludarabine—lymphatic system cancer	0.00146	0.00458	CcSEcCtD
Ticlopidine—Arthralgia—Fludarabine—lymphatic system cancer	0.00146	0.00458	CcSEcCtD
Ticlopidine—Haemoglobin—Bleomycin—lymphatic system cancer	0.00145	0.00456	CcSEcCtD
Ticlopidine—Haemorrhage—Bleomycin—lymphatic system cancer	0.00144	0.00453	CcSEcCtD
Ticlopidine—Pancytopenia—Vincristine—lymphatic system cancer	0.00143	0.00448	CcSEcCtD
Ticlopidine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0014	0.00439	CcSEcCtD
Ticlopidine—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00139	0.00437	CcSEcCtD
Ticlopidine—Decreased appetite—Teniposide—lymphatic system cancer	0.00138	0.00435	CcSEcCtD
Ticlopidine—Renal failure—Carmustine—lymphatic system cancer	0.00138	0.00433	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00138	0.00432	CcSEcCtD
Ticlopidine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00137	0.00431	CcSEcCtD
Ticlopidine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00137	0.0043	CcSEcCtD
Ticlopidine—Rash—Mechlorethamine—lymphatic system cancer	0.00136	0.00428	CcSEcCtD
Ticlopidine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00136	0.00427	CcSEcCtD
Ticlopidine—Anorexia—Fludarabine—lymphatic system cancer	0.00133	0.00419	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00131	0.00413	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.0013	0.00409	CcSEcCtD
Ticlopidine—Renal failure—Mitoxantrone—lymphatic system cancer	0.00128	0.00403	CcSEcCtD
Ticlopidine—Nausea—Mechlorethamine—lymphatic system cancer	0.00128	0.00403	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00127	0.004	CcSEcCtD
Ticlopidine—Haemoglobin—Carmustine—lymphatic system cancer	0.00127	0.00398	CcSEcCtD
Ticlopidine—Urticaria—Teniposide—lymphatic system cancer	0.00126	0.00397	CcSEcCtD
Ticlopidine—Haemorrhage—Carmustine—lymphatic system cancer	0.00126	0.00396	CcSEcCtD
Ticlopidine—Body temperature increased—Teniposide—lymphatic system cancer	0.00126	0.00395	CcSEcCtD
Ticlopidine—Haematuria—Mitoxantrone—lymphatic system cancer	0.00124	0.00391	CcSEcCtD
Ticlopidine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00123	0.00387	CcSEcCtD
Ticlopidine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00122	0.00382	CcSEcCtD
Ticlopidine—Pain—Fludarabine—lymphatic system cancer	0.0012	0.00376	CcSEcCtD
Ticlopidine—Vasculitis—Methotrexate—lymphatic system cancer	0.00119	0.00374	CcSEcCtD
Ticlopidine—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00118	0.0037	CcSEcCtD
Ticlopidine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00117	0.00368	CcSEcCtD
Ticlopidine—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00117	0.00368	CcSEcCtD
Ticlopidine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00117	0.00368	CcSEcCtD
Ticlopidine—Asthenia—Teniposide—lymphatic system cancer	0.00114	0.00359	CcSEcCtD
Ticlopidine—Pruritus—Teniposide—lymphatic system cancer	0.00113	0.00354	CcSEcCtD
Ticlopidine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00111	0.00347	CcSEcCtD
Ticlopidine—Diarrhoea—Teniposide—lymphatic system cancer	0.00109	0.00342	CcSEcCtD
Ticlopidine—Myalgia—Bleomycin—lymphatic system cancer	0.00107	0.00336	CcSEcCtD
Ticlopidine—Ecchymosis—Methotrexate—lymphatic system cancer	0.00105	0.0033	CcSEcCtD
Ticlopidine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00103	0.00324	CcSEcCtD
Ticlopidine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00103	0.00322	CcSEcCtD
Ticlopidine—Vomiting—Teniposide—lymphatic system cancer	0.00101	0.00318	CcSEcCtD
Ticlopidine—Sepsis—Methotrexate—lymphatic system cancer	0.00101	0.00317	CcSEcCtD
Ticlopidine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.001	0.00315	CcSEcCtD
Ticlopidine—Asthenia—Fludarabine—lymphatic system cancer	0.001	0.00315	CcSEcCtD
Ticlopidine—Rash—Teniposide—lymphatic system cancer	0.001	0.00315	CcSEcCtD
Ticlopidine—Dermatitis—Teniposide—lymphatic system cancer	0.001	0.00315	CcSEcCtD
Ticlopidine—Headache—Teniposide—lymphatic system cancer	0.000997	0.00313	CcSEcCtD
Ticlopidine—Pruritus—Fludarabine—lymphatic system cancer	0.000989	0.00311	CcSEcCtD
Ticlopidine—Anorexia—Bleomycin—lymphatic system cancer	0.000977	0.00307	CcSEcCtD
Ticlopidine—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00097	0.00305	CcSEcCtD
Ticlopidine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000957	0.00301	CcSEcCtD
Ticlopidine—Nausea—Teniposide—lymphatic system cancer	0.000945	0.00297	CcSEcCtD
Ticlopidine—Hepatic failure—Methotrexate—lymphatic system cancer	0.000939	0.00295	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000934	0.00293	CcSEcCtD
Ticlopidine—Myalgia—Carmustine—lymphatic system cancer	0.000934	0.00293	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000894	0.00281	CcSEcCtD
Ticlopidine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000891	0.0028	CcSEcCtD
Ticlopidine—Myalgia—Vincristine—lymphatic system cancer	0.000891	0.0028	CcSEcCtD
Ticlopidine—Vomiting—Fludarabine—lymphatic system cancer	0.000889	0.00279	CcSEcCtD
Ticlopidine—Rash—Fludarabine—lymphatic system cancer	0.000882	0.00277	CcSEcCtD
Ticlopidine—Dermatitis—Fludarabine—lymphatic system cancer	0.000881	0.00277	CcSEcCtD
Ticlopidine—Pain—Bleomycin—lymphatic system cancer	0.000877	0.00275	CcSEcCtD
Ticlopidine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000876	0.00275	CcSEcCtD
Ticlopidine—Headache—Fludarabine—lymphatic system cancer	0.000876	0.00275	CcSEcCtD
Ticlopidine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000868	0.00273	CcSEcCtD
Ticlopidine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000868	0.00273	CcSEcCtD
Ticlopidine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000854	0.00268	CcSEcCtD
Ticlopidine—Anorexia—Carmustine—lymphatic system cancer	0.000853	0.00268	CcSEcCtD
Ticlopidine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000844	0.00265	CcSEcCtD
Ticlopidine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000837	0.00263	CcSEcCtD
Ticlopidine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000832	0.00261	CcSEcCtD
Ticlopidine—Nausea—Fludarabine—lymphatic system cancer	0.000831	0.00261	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000815	0.00256	CcSEcCtD
Ticlopidine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000815	0.00256	CcSEcCtD
Ticlopidine—Urticaria—Bleomycin—lymphatic system cancer	0.000815	0.00256	CcSEcCtD
Ticlopidine—Anorexia—Vincristine—lymphatic system cancer	0.000814	0.00256	CcSEcCtD
Ticlopidine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000811	0.00255	CcSEcCtD
Ticlopidine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000793	0.00249	CcSEcCtD
Ticlopidine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000779	0.00245	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000778	0.00245	CcSEcCtD
Ticlopidine—Decreased appetite—Carmustine—lymphatic system cancer	0.000778	0.00244	CcSEcCtD
Ticlopidine—Pain—Carmustine—lymphatic system cancer	0.000765	0.0024	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000758	0.00238	CcSEcCtD
Ticlopidine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000755	0.00237	CcSEcCtD
Ticlopidine—Decreased appetite—Vincristine—lymphatic system cancer	0.000743	0.00233	CcSEcCtD
Ticlopidine—Asthenia—Bleomycin—lymphatic system cancer	0.000736	0.00231	CcSEcCtD
Ticlopidine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000732	0.0023	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000732	0.0023	CcSEcCtD
Ticlopidine—Pain—Vincristine—lymphatic system cancer	0.000731	0.0023	CcSEcCtD
Ticlopidine—Pruritus—Bleomycin—lymphatic system cancer	0.000725	0.00228	CcSEcCtD
Ticlopidine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000723	0.00227	CcSEcCtD
Ticlopidine—Eosinophilia—Methotrexate—lymphatic system cancer	0.000722	0.00227	CcSEcCtD
Ticlopidine—Pain—Mitoxantrone—lymphatic system cancer	0.000712	0.00224	CcSEcCtD
Ticlopidine—Body temperature increased—Carmustine—lymphatic system cancer	0.000708	0.00222	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000699	0.00219	CcSEcCtD
Ticlopidine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000692	0.00218	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00068	0.00214	CcSEcCtD
Ticlopidine—Body temperature increased—Vincristine—lymphatic system cancer	0.000675	0.00212	CcSEcCtD
Ticlopidine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000661	0.00208	CcSEcCtD
Ticlopidine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000659	0.00207	CcSEcCtD
Ticlopidine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000658	0.00207	CcSEcCtD
Ticlopidine—Vomiting—Bleomycin—lymphatic system cancer	0.000652	0.00205	CcSEcCtD
Ticlopidine—Rash—Bleomycin—lymphatic system cancer	0.000647	0.00203	CcSEcCtD
Ticlopidine—Dermatitis—Bleomycin—lymphatic system cancer	0.000646	0.00203	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000644	0.00202	CcSEcCtD
Ticlopidine—Asthenia—Carmustine—lymphatic system cancer	0.000642	0.00202	CcSEcCtD
Ticlopidine—Renal failure—Methotrexate—lymphatic system cancer	0.000639	0.00201	CcSEcCtD
Ticlopidine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00063	0.00198	CcSEcCtD
Ticlopidine—Haematuria—Methotrexate—lymphatic system cancer	0.00062	0.00195	CcSEcCtD
Ticlopidine—Epistaxis—Methotrexate—lymphatic system cancer	0.000613	0.00193	CcSEcCtD
Ticlopidine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000613	0.00193	CcSEcCtD
Ticlopidine—Asthenia—Vincristine—lymphatic system cancer	0.000613	0.00193	CcSEcCtD
Ticlopidine—Diarrhoea—Carmustine—lymphatic system cancer	0.000612	0.00192	CcSEcCtD
Ticlopidine—Nausea—Bleomycin—lymphatic system cancer	0.000609	0.00191	CcSEcCtD
Ticlopidine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000597	0.00188	CcSEcCtD
Ticlopidine—Dizziness—Carmustine—lymphatic system cancer	0.000592	0.00186	CcSEcCtD
Ticlopidine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000587	0.00184	CcSEcCtD
Ticlopidine—Diarrhoea—Vincristine—lymphatic system cancer	0.000585	0.00184	CcSEcCtD
Ticlopidine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000584	0.00183	CcSEcCtD
Ticlopidine—Hepatitis—Methotrexate—lymphatic system cancer	0.000584	0.00183	CcSEcCtD
Ticlopidine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000569	0.00179	CcSEcCtD
Ticlopidine—Vomiting—Carmustine—lymphatic system cancer	0.000569	0.00179	CcSEcCtD
Ticlopidine—Dizziness—Vincristine—lymphatic system cancer	0.000565	0.00177	CcSEcCtD
Ticlopidine—Rash—Carmustine—lymphatic system cancer	0.000564	0.00177	CcSEcCtD
Ticlopidine—Dermatitis—Carmustine—lymphatic system cancer	0.000564	0.00177	CcSEcCtD
Ticlopidine—Headache—Carmustine—lymphatic system cancer	0.000561	0.00176	CcSEcCtD
Ticlopidine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000552	0.00173	CcSEcCtD
Ticlopidine—Tinnitus—Methotrexate—lymphatic system cancer	0.000544	0.00171	CcSEcCtD
Ticlopidine—Vomiting—Vincristine—lymphatic system cancer	0.000543	0.00171	CcSEcCtD
Ticlopidine—Rash—Vincristine—lymphatic system cancer	0.000539	0.00169	CcSEcCtD
Ticlopidine—Dermatitis—Vincristine—lymphatic system cancer	0.000538	0.00169	CcSEcCtD
Ticlopidine—Headache—Vincristine—lymphatic system cancer	0.000535	0.00168	CcSEcCtD
Ticlopidine—Nausea—Carmustine—lymphatic system cancer	0.000532	0.00167	CcSEcCtD
Ticlopidine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000529	0.00166	CcSEcCtD
Ticlopidine—Rash—Mitoxantrone—lymphatic system cancer	0.000525	0.00165	CcSEcCtD
Ticlopidine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000524	0.00165	CcSEcCtD
Ticlopidine—Headache—Mitoxantrone—lymphatic system cancer	0.000521	0.00164	CcSEcCtD
Ticlopidine—Nausea—Vincristine—lymphatic system cancer	0.000508	0.00159	CcSEcCtD
Ticlopidine—Nausea—Mitoxantrone—lymphatic system cancer	0.000494	0.00155	CcSEcCtD
Ticlopidine—Myalgia—Methotrexate—lymphatic system cancer	0.000432	0.00136	CcSEcCtD
Ticlopidine—Arthralgia—Methotrexate—lymphatic system cancer	0.000432	0.00136	CcSEcCtD
Ticlopidine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000415	0.0013	CcSEcCtD
Ticlopidine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000406	0.00128	CcSEcCtD
Ticlopidine—Anorexia—Methotrexate—lymphatic system cancer	0.000395	0.00124	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000378	0.00119	CcSEcCtD
Ticlopidine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000365	0.00115	CcSEcCtD
Ticlopidine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00036	0.00113	CcSEcCtD
Ticlopidine—Pain—Methotrexate—lymphatic system cancer	0.000355	0.00111	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000339	0.00107	CcSEcCtD
Ticlopidine—Urticaria—Methotrexate—lymphatic system cancer	0.000329	0.00103	CcSEcCtD
Ticlopidine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000328	0.00103	CcSEcCtD
Ticlopidine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000305	0.00096	CcSEcCtD
Ticlopidine—Asthenia—Methotrexate—lymphatic system cancer	0.000297	0.000934	CcSEcCtD
Ticlopidine—Pruritus—Methotrexate—lymphatic system cancer	0.000293	0.000921	CcSEcCtD
Ticlopidine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000284	0.000891	CcSEcCtD
Ticlopidine—Dizziness—Methotrexate—lymphatic system cancer	0.000274	0.000861	CcSEcCtD
Ticlopidine—Vomiting—Methotrexate—lymphatic system cancer	0.000264	0.000828	CcSEcCtD
Ticlopidine—Rash—Methotrexate—lymphatic system cancer	0.000261	0.000821	CcSEcCtD
Ticlopidine—Dermatitis—Methotrexate—lymphatic system cancer	0.000261	0.00082	CcSEcCtD
Ticlopidine—Headache—Methotrexate—lymphatic system cancer	0.00026	0.000816	CcSEcCtD
Ticlopidine—Nausea—Methotrexate—lymphatic system cancer	0.000246	0.000774	CcSEcCtD
